Patent · US Expired

Substituted tetrapeptides

US4595677A · kind A · utility

10Cited by
8References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 23, 1983
Grant dateJun 17, 1986
Priority date
Expiry dateNov 23, 2003

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/86
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Tetrapeptides of the formula I, ##STR1## in which R.sup.1 represents hydrogen or acyl, R.sup.2 represents alkyl or aralkyl, R.sup.3 represents free or functionally modified hydroxy, R.sup.4 represents free or substituted amino or free or etherified hydroxy, and -Pro-, -Phe- and -His- respectively represent the bivalent radicals of the amino acids proline, phenylalanine and histidine or the (D)-isomers thereof, salts of such compounds having salt-forming groups, and processes for their manufacture. The compounds inhibit the action of the enzyme renin and can be used as antihypertensives and for the treatment of cardiac insufficiency.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.